Suppr超能文献

慢性阻塞性肺疾病急性加重期的血清甘油磷脂谱

Serum Glycerophospholipid Profile in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

作者信息

Gai Xiaoyan, Guo Chenglin, Zhang Linlin, Zhang Lijiao, Abulikemu Mairipaiti, Wang Juan, Zhou Qingtao, Chen Yahong, Sun Yongchang, Chang Chun

机构信息

Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.

出版信息

Front Physiol. 2021 Feb 15;12:646010. doi: 10.3389/fphys.2021.646010. eCollection 2021.

Abstract

Studies have shown that glycerophospholipids are involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). This study adopted targeted metabolomic analysis to investigate the changes in serum glycerophospholipids in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and their differential expression in patients with different inflammatory subtypes. Patients with AECOPD admitted between January 2015 and December 2017 were enrolled, and their clinical data were collected. The patients' gender, age, body mass index, and lung function were recorded. Routine blood and induced sputum tests were performed. Liquid chromatography-mass spectrometry was used to detect the serum glycerophospholipid metabolic profiles and to analyze the metabolic profile changes between the acute exacerbation and recovery stages as well as the differences between different inflammatory subtypes. A total of 58 patients were hospitalized for AECOPD, including 49 male patients with a mean age of 74.8 ± 10.0 years. In the metabolic profiles, the expression of lysophosphatidylcholine (LPC) 18:3, lysophosphatidylethanolamine (LPE) 16:1, and phosphatidylinositol (PI) 32:1 was significantly reduced in the acute exacerbation stage compared to the recovery stage ( < 0.05). The three glycerophospholipids were used to plot the receiver operating characteristic curves to predict the acute exacerbation/recovery stage, and the areas under the curves were all above 70%. There were no differential metabolites between the two groups of patients with blood eosinophil percentage (EOS%) ≥2% and <2% at exacerbation. The expression of LPC 18:3, LPE 16:1, and PI 32:1 was significantly reduced in the acute exacerbation stage compared to the recovery stage in the inflammatory subtype with blood EOS <2% ( < 0.05). Abnormalities in the metabolism of glycerophospholipids may be involved in the onset of AECOPD, especially in the non-eosinophilic subtype.

摘要

研究表明,甘油磷脂参与慢性阻塞性肺疾病(COPD)的发病机制。本研究采用靶向代谢组学分析方法,以探究慢性阻塞性肺疾病急性加重期(AECOPD)患者血清甘油磷脂的变化及其在不同炎症亚型患者中的差异表达。选取2015年1月至2017年12月期间收治的AECOPD患者,收集其临床资料。记录患者的性别、年龄、体重指数及肺功能。进行血常规和诱导痰检测。采用液相色谱 - 质谱联用技术检测血清甘油磷脂代谢谱,分析急性加重期与缓解期之间的代谢谱变化以及不同炎症亚型之间的差异。共有58例患者因AECOPD住院,其中男性49例,平均年龄74.8±10.0岁。在代谢谱中,与缓解期相比,急性加重期溶血磷脂酰胆碱(LPC)18:3、溶血磷脂酰乙醇胺(LPE)16:1和磷脂酰肌醇(PI)32:1的表达显著降低(<0.05)。利用这三种甘油磷脂绘制受试者工作特征曲线以预测急性加重期/缓解期,曲线下面积均大于70%。急性加重期血嗜酸性粒细胞百分比(EOS%)≥2%和<2%的两组患者之间无差异代谢物。在血EOS<2%的炎症亚型中,与缓解期相比,急性加重期LPC

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验